Literature DB >> 28507499

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult.

Qiu-Xia Mao1,2, Wan-Lu Zhang1, Qiang Wang1, Xue-Min Xiao1, Hao Chen1, Xue-Bao Shao1, Hong Jia1, Su-Ying Feng1, Jian-Bing Wu1, Cheng-Rang Li1.   

Abstract

Entities:  

Year:  2017        PMID: 28507499      PMCID: PMC5420612          DOI: 10.5114/ada.2017.67086

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


× No keyword cloud information.
Linear cutaneous lupus erythematosus (LCLE) is rare. The LCLE was proposed by Abe et al. [1] for discoid lupus erythematosus (DLE) with a linear configuration in 1988. It occurs mainly in children and young adults. Lesions appear as linear unilateral erythematous plaques following the Blaschko lines and are observed most frequently on the face, although the neck, trunk and extremities may also be affected [2]. Neither photosensitivity nor progression to systemic LE is observed [3]. To our knowledge, only 9 cases in adults have been reported in the literature. We report here the tenth case in an adult. A 32-year-old woman presented with a 1-month history of slightly pruritic plaque on her left jaw and neck. These lesions first appeared on her jaw and spread to the left side of the neck in a linear arrangement. There was no history of trauma around the lesions, nor of intensive exposure to sunlight. The patient reported no fever, chills or photosensitivity. Her past medical history was unremarkable and there was no similar condition reported in her family members. On physical examination, she had linear, slightly atrophic, reddish-brown plaque on her left jaw and neck (Figure 1 A) which did not follow the lines of Blaschko strictly (Figure 1 B). Laboratory investigations revealed positive antinuclear antibodies (ANA) with a titer of 1 : 80 (normal: < 1 : 40) and a granular fluorescence pattern, decreased complement C4 of 0.13 g/l (normal: 0.17–4 g/l) and decreased leukocyte of 3.62 × 109/l (normal: 4–10 × 109/l). Liver function tests, blood urea, creatinine and urine analysis were within normal limits. Antibodies against doublestranded DNA and Sm were negative. Skin biopsy from the lesion on the jaw revealed epidermal atrophy, follicular plugging and liquefaction degeneration in the basal layer of the epidermis. In the underlying dermis, inflammatory infiltrates of lymphocytes around the adnexal and vascular structures were observed (Figures 2 A, B). Alcian blue staining did not reveal obvious mucin depositions in the dermis (Figure 2 C). Direct immunofluorescence was not performed. Based on the clinical, laboratory, and histological findings, a diagnosis of LCLE was made. The patient was injected with 1 ml of a betamethasone injection and was also treated with desonide cream and tacrolimus 0.1% ointment for 1 month, the lesions stopped spreading and became darker (Figure 1 C).
Figure 1

A – The linear, slightly atrophic, reddish-brown plaque on the left jaw and neck following Blaschko lines generally; B – distribution of the Blaschko lines on the plaque on the head and neck (pattern elaborated by Happle and Assim [11]); C – the lesions stopped spreading and became darker after treatment

Figure 2

A – Skin biopsy specimen from the jaw showing epidermal atrophy, follicular plugging, inflammatory infiltrates of lymphocytes around the adnexal and vascular structures in the dermis (hematoxylin and eosin, 100×); B – liquefaction degeneration in the basal layer of the epidermis (hematoxylin and eosin, 200×); C – Alcian blue staining did not reveal obvious mucin depositions in the dermis (Alcian blue staining, 100×)

A – The linear, slightly atrophic, reddish-brown plaque on the left jaw and neck following Blaschko lines generally; B – distribution of the Blaschko lines on the plaque on the head and neck (pattern elaborated by Happle and Assim [11]); C – the lesions stopped spreading and became darker after treatment A – Skin biopsy specimen from the jaw showing epidermal atrophy, follicular plugging, inflammatory infiltrates of lymphocytes around the adnexal and vascular structures in the dermis (hematoxylin and eosin, 100×); B – liquefaction degeneration in the basal layer of the epidermis (hematoxylin and eosin, 200×); C – Alcian blue staining did not reveal obvious mucin depositions in the dermis (Alcian blue staining, 100×) The LCLE is a highly unusual variation of discoid lupus erythematosus (DLE) [4]. In 1998, when reporting 2 cases of linear childhood CLE following the lines of Blaschko, Abe et al. [1] proposed the term ‘linear cutaneous lupus erythematosus (LCLE)’ for DLE with a linear configuration. Nevertheless, other subtypes of LE that follow a linear pattern have already been described, including deep LE, subacute LE and tumid LE. The LCLE occurs mainly in children and young adults, with a similar incidence in both sexes, without ethnic preference. Lesions appear as linear unilateral erythematous plaques and are observed most frequently on the face, although the neck, trunk and extremities may also be affected [2]. Most commonly, anti-nuclear antibodies are negative or slightly positive. Neither photosensitivity nor progression to systemic LE is observed. The histological findings in LCLE include hyperkeratosis, atrophy of the epidermis, hydropic degeneration of the basal cell layer in the epidermis, perivascular and periadnexal dense infiltrates of lymphocytes, and mucinous deposition in the dermis. These findings are compatible with DLE [3]. Differential diagnosis must be established with other conditions with Blaschko linear distribution such as linear lichen planus, lichen striatus, linear granuloma annulare, linear psoriasis, morphea or inflammatory linear verrucous epidermal nevus [2]. The treatment of linear cutaneous LE includes potent topical corticosteroids or calcineurin inhibitors. In more widespread disease, systemic corticosteroids, methotrexate, chloroquine or hydroxychloroquine or other immunosuppressants may be necessary [5]. In most cases the age of onset is younger than 15 years. To our knowledge, there have been only nine previous confirmed cases of LCLE/DLE in adults, which all followed Blaschko lines [2, 5–11] (Table 1). The incidence in both sexes seemed similar. The lesions occurred mainly on the face. Testing for antinuclear antibodies was positive in 2 of the cases. Laboratory tests of blood cell count were all normal. The treatment mainly included hydroxychloroquine, topical steroid and sunblock, which led to the lesions being stable or significantly improved, even complete resolution. Our patient represents the 10th case and this is the first reported case in China in the English literature. It is unique that the lesions in our case were slightly different from the typical line patterns of Blaschko (Figure 1 B) which was elaborated by Happle and Assim [12] on the head and neck in 2001. There may be some variation among different ethnic groups or different individuals of the same race. In our case ANA was positive along with decreased complement C4 and leukocyte which had never presented in the nine previous cases. After treatment with 1 ml of betamethasone injection, topical corticosteroids and tacrolimus 0.1% ointment for 1 month, the lesions stopped spreading and became darker.
Table 1

Summary of cases of linear cutaneous lupus erythematosus/discoid lupus erythematosus in adults

AuthorAge of onsetGenderDistribution (site)AntibodiesDIFBlood cell countsTXCTEfficacy
Bouzit et al. (1999) [5]29FForehead(–)+NormalHCQ + TS2 monthsCR
Abe et al. (2000) [6]23MCheek(–)+NormalDDS28 daysSI
Sàbat et al. (2006) [7]19FNose and epicanthal areaANA(+)NDNormalHCQ1 yearStable
Gaitanis et al. (2009) [8]21MSupraorbital area, infraorbitally and mouth angle(–)+NormalHCQ + TS + SB2 yearsCR
Thind et al. (2009) [9]37FMouth, chin(–)+NormalTS + SBNMStable
Kim et al. (2010) [10]33MForehead, nose(–)NDNormalHCQ + TSNMSI
Alcántara-González et al. (2011) [2]64MNeck(–)NDNormalTS2 monthsCR
Alcántara-González et al. (2011) [2]45MHead(–)NDNormalTS3 monthsSI
Verma et al. (2012) [4]32FFace, upper back and extremitiesANA(+)NDNormalTS + MTX + SBNMSI
Our case (2015)32FJaw and neckANA(+), CC4(+)NDDecreased leukocyteTS + SS + TT1 monthMI

F – female, M – male, ANA – antinuclear antibody, CC4 – complement C4, DIF – direct immunofluorescence, ND – not done, TX – treatment, HCQ – hydroxychloroquine, TS – topical steroid, DDS – diaminodiphenylsulfone, SB – sunblock, MTX – methotrexate, SS – systemic steroid, TT – topical tacrolimus, CT – course of treatment, NM – not mentioned, CR – complete resolution, SI – significantly improved, MI – mildly improved.

Summary of cases of linear cutaneous lupus erythematosus/discoid lupus erythematosus in adults F – female, M – male, ANA – antinuclear antibody, CC4 – complement C4, DIF – direct immunofluorescence, ND – not done, TX – treatment, HCQ – hydroxychloroquine, TS – topical steroid, DDS – diaminodiphenylsulfone, SB – sunblock, MTX – methotrexate, SS – systemic steroid, TT – topical tacrolimus, CT – course of treatment, NM – not mentioned, CR – complete resolution, SI – significantly improved, MI – mildly improved. Here we report the 10th case of LCLE/DLE occurring in an adult. The clinical presentation of LCLE in children and adults seems to be similar, with a similar incidence in both sexes, essentially involving the face. The differential diagnosis of such linear lesions includes lichen striatus and linear lichen planus. In patients presenting with a linear inflammatory eruption on the face, a skin biopsy should be performed to rule out a linear form of cutaneous lupus erythematosus.
  12 in total

1.  The lines of Blaschko on the head and neck.

Authors:  R Happle; A Assim
Journal:  J Am Acad Dermatol       Date:  2001-04       Impact factor: 11.527

2.  Guess what? Linear cutaneous lupus erythematous (LCLE): relationship with Blaschko's lines.

Authors:  M Abe; K Ohnishi; O Ishikawa
Journal:  Eur J Dermatol       Date:  2000 Apr-May       Impact factor: 3.328

3.  Chronic disseminated discoid lupus erythematosus with linear lesions following Blaschko's lines on forearm and hand.

Authors:  Shyam B Verma; Uwe Wollina
Journal:  J Dtsch Dermatol Ges       Date:  2011-09-22       Impact factor: 5.584

4.  A rare linear atrophic lesion on the face.

Authors:  C K Thind; E A Husain; J Hewitt
Journal:  Clin Exp Dermatol       Date:  2009-10       Impact factor: 3.470

5.  Linear cutaneous lupus erythematosus on the midline of the face.

Authors:  Jihyun Kim; Sang H Lee; Mi R Roh
Journal:  J Dermatol       Date:  2010-09-20       Impact factor: 4.005

6.  Extraordinarily long linear cutaneous lupus erythematosus along the lines of Blaschko.

Authors:  Akiteru Aiyama; Yoshinao Muro; Kazumitsu Sugiura; Hiroki Onouchi; Masashi Akiyama
Journal:  Dermatol Online J       Date:  2013-07-14

Review 7.  Linear cutaneous lupus erythematosus in an adult.

Authors:  N Bouzit; P Grézard; F Wolf; B Balme; H Perrot
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

8.  Linear cutaneous lupus erythematosus: a subset of childhood cutaneous lupus erythematosus.

Authors:  G Gaitanis; K Nomikos; I Chaniotakis; C Stergiopoulou; A Zioga; I Bassukas
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

9.  Linear cutaneous lupus erythematosus following the lines of Blaschko.

Authors:  M Abe; O Ishikawa; Y Miyachi
Journal:  Br J Dermatol       Date:  1998-08       Impact factor: 9.302

10.  Clinical characteristics of cutaneous lupus erythematosus.

Authors:  Justyna Szczęch; Maja Rutka; Dominik Samotij; Agnieszka Zalewska; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

View more
  1 in total

1.  Adult-onset linear discoid lupus erythematosus on the forehead mimicking en coup de sabre: a case report.

Authors:  Sasipaka Sindhusen; Kumutnart Chanprapaph; Suthinee Rutnin
Journal:  J Med Case Rep       Date:  2019-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.